Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 558Leukemia 281Precursor Cell Lymphoblastic Leukemia-Lymphoma 231Lymphoma 159Myelodysplastic Syndromes 110Burkitt Lymphoma 90Congenital Abnormalities 85Lymphoma, Non-Hodgkin 84Leukemia, Monocytic, Acute 83Leukemia, Myelomonocytic, Acute 81Lymphoma, Large B-Cell, Diffuse 79Leukemia, Erythroblastic, Acute 74Leukemia, Megakaryoblastic, Acute 71Recurrence 69Lymphoma, Mantle-Cell 69Lymphoma, Follicular 48Leukemia, Myelomonocytic, Chronic 43Leukemia, Biphenotypic, Acute 43Hodgkin Disease 43Lymphoma, Large-Cell, Immunoblastic 36Blast Crisis 36Anemia, Refractory, with Excess of Blasts 36Leukemia, Myelogenous, Chronic, BCR-ABL Positive 35Leukemia, Lymphocytic, Chronic, B-Cell 32Myeloproliferative Disorders 30Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 27Lymphoma, B-Cell, Marginal Zone 23Leukemia, Myeloid, Chronic-Phase 23Leukemia, Eosinophilic, Acute 23Leukemia, Basophilic, Acute 22

Interventions

Cyclophosphamide 22fludarabine phosphate 19Whole-Body Irradiation 17fludarabine 15Melphalan 15Tacrolimus 14Busulfan 13Peripheral Blood Stem Cell Transplantation 11Mycophenolic Acid 11Alemtuzumab 9Cyclosporine 7Methotrexate 6Antilymphocyte Serum 6thymoglobulin 4Stem Cell Transplantation 4Thiotepa 3Methylprednisolone 3Granulocyte Colony-Stimulating Factor 3Etoposide 3AP 1903 reagent 3sargramostim 2Transplantation 2Sirolimus 2Rituximab 2Hematopoietic Stem Cell Transplantation 2Filgrastim 2Cord Blood Stem Cell Transplantation 2visilizumab 1posaconazole 1nicotinamide-beta-riboside 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Anemia, Aplastic × Cytarabine × Clear all
NCT01500161 2013-11-25

Pooled Unrelated Donor Umbilical Cord Blood Transplant For Hematologic Malignancy Needing Allogeneic Stem Cell Transplant Without Related HLA-Match

Texas Oncology Cancer Center

Phase 2 Terminated
1 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cell

Anemia, Aplastic, Anemia, Refractory, with Excess of Blasts, Hodgkin Disease, Leukemia, Lymphoma, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡